4.4 Article

Peroxisome proliferator-activated receptor. and colorectal cancer

Journal

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
Volume 2, Issue 3, Pages 159-164

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4251/wjgo.v2.i3.159

Keywords

Colorectal cancer; Peroxisome proliferator-activated receptors; Ligand; Tumor suppression

Ask authors/readers for more resources

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily and ligand-activated transcription factors. PPAR. plays an important role in adipocyte differentiation, lipid storage and energy dissipation in adipose tissue, and is involved in the control of inflammatory reactions as well as in glucose metabolism through the improvement of insulin sensitivity. Growing evidence has demonstrated that activation of PPAR. has an antineoplastic effect in tumors, including colorectal cancer. High expression of PPAR. is detected in human colon cancer cell lines and adenocarcinoma. This review describes the molecular mechanisms by which PPAR. regulates tumorigenesis in colorectal cancer, and examines current clinical trials evaluating PPAR. agonists as therapeutic agents for colorectal cancer. (C) 2010 Baishideng. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available